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We examined protective and non-protective effects of disadvantaged social identities and their 
intersections on lifetime substance use and risky alcohol consumption. 
 
Methods 
Data from 90,941 participants of the Global Drug Survey 2015 were analysed. Multivariable logistic 
regressions were used to calculate adjusted odds ratios for lifetime use of 9 psychoactive substances, as 
well as high risk/harmful alcohol use. Disadvantaged identities from three categories (ethnicity, sexual 
identity, gender), and interactions between these were compared. 
 
Results 
Findings indicate that participants with disadvantaged ethnic and sexual minority identities are more 
likely to use psychoactive substances compared to their counterparts. The intersecting identity 
‘disadvantaged ethnic identity and sexual minority’ appears to be protective compared to those with 
just one of these identities. While female gender appears to be highly protective in general, it is not 
protective among females with disadvantaged social identities. 
 
Conclusion 
Stark disparities in substance use between different social identities and their intersections emphasise 
the importance of intersectionality theories in public health research intervention design. Future 







Intersectionality refers to the interconnected nature of social categorizations such as 
race/ethnicity, class or socio-economic status, sexual identity, and gender as they apply to a given 
individual or group, and draws attention to overlapping and interdependent systems of discrimination 
or disadvantage (Bowleg 2012; Rogers and Kelly 2011; O’Brien 2016). Thus, it is a conceptual tool for 
research and critical thought into how disadvantage is experienced within different social minority 
groups, and in particular, for considering and acknowledging those who fall into multiple groups 
(Molina et al 2016; Creswell 2014; Vardeman-Winter et al 2013; Bauer 2014). It is drawn from a socio-
political theoretical framework aimed at understanding how people, who fall into multiple groups across 
categories experience increased social oppression (Rogers and Kelly 2011). Intersectionality often 
concentrates on social advantages and disadvantages associated with certain identities, and their 
consequences on social, emotional, physical, and mental wellbeing (Read and Eagle 2011). In this 
context, identities that experience societal oppression based on their identity are defined as 
‘disadvantaged identities’ whereas identities not experiencing such oppression are defined as socially 
advantaged identities such as ‘heterosexuals’, ‘men’, or ‘white people’ (Watt 2007). Research into 
intersecting social identities is relatively new and currently not widely applied in public health research. 
In particular, little is known about intersectionality as a risk or a protective factor, nor about how specific 
intersecting identities affect health-related behaviours, morbidity, and mortality rates (Etherington 
2015; Hankivsky et al. 2014). Advocates for the use of intersectionality as a research paradigm argue 
that without consideration of this framework in both theoretical and empirical studies, populations 
continue to be studied in ways that eliminate a consideration of the complex social realities of many 
sub-groups and individuals, and fail to take into account power inequity as it affects human health and 
wellbeing (Rogers and Kelly, 2011). Importantly, this theoretical lens allows us to examine variable 
relationships that we might expect to have compounding effects on disadvantage and health (Carliner 
et al. 2016; Clark et al. 2018). 
Bowleg (2012) described intersectionality as crucial in light of public health’s commitment to 
social justice, and states that health research cannot intelligently keep studies that take intersectionality 
into account a rarity. She argues that it should be an inherent part of health inequalities research due to 
its ability to ‘reflect multiple interlocking systems of privilege and oppression at the macro and social-
structural levels, including racism, sexism, and heterosexism’ (pg. 1267). Bauer (2014) agreed in so far 
as it should be used as a tool to generate evidence for the existence of intra-group and inter-group health 
inequalities that require a unique and contextually sensitive response in order to create and sustain social 
and public health progressions toward equity. 
Beyond the use of this framework to drive the generation of epidemiological data as an 
evidence-base for social complexity and clusters in health inequalities, many researchers have recently 




social marketing, public health interventions, and the delivery of primary health care (Vardeman-Winter 
et al. 2013). Researchers in interdisciplinary fields, such as health-communication, found that 
campaigns and interventions require extensive research into the differing salient identities comprising 
target groups prior to efforts to instigate behavioural change, screening, and healthcare delivery (Nölke 
2018; O’Brien 2016; Bauer 2014). As per any successful marketing or mass communication campaign, 
sub-groups who together compromise large sections of society - and who are often the target audiences 
for messages about lifestyle change and health - need to be comprehensively studied for insights into 
their unique living contexts. Viruell-Fuentes et al. (2012) made a progressive case for a shift away from 
assuming an understanding of the determinants of ill-health in these groups, and dedicated a specific 
research effort to going beyond cultural barriers to health in migrants. They suggested the varying 
structural inequalities experienced by different subsections of this group as more useful mechanisms 
and bases for designing interventions. This would help take into account unforeseen or seemingly 
‘invisible’ structural barriers to health that more social advantaged or categorically less complex groups 
do not experience or express.  
Some studies have found that if intersectionality is ignored in health service provision, the 
nature and quality of that service is compromised (Etherington 2017; Kelly and Rogers 2011). O’Brien 
et al. (2016) pointed to the need for considerations of gender and social class when providing services 
for services of domestic violence abuse (DVA), without which recipients of services feel misunderstood 
and undermined. Creswell (2014) noted that taking an intersectional approach to researching the needs 
of black women in the US generated outcomes that pointed to the need for taking stronger account of 
experiences of homelessness and overall mistrust of the system when delivering in-hospital care to these 
women. Hankivsky et al. (2014) advocated for an overall intersectionality-based policy analysis 
framework as a practical means to effectively redressing inequality, and for producing more inclusive 
and socially just platforms for service delivery. In particular, Hankivsky et al. (2014) argued that while 
we have looked at men’s health, women’s health, and gender and health per se, we need an integration 
of these research efforts to understand common struggles faced in each field, such as in the context of 
health services for those living with HIV/AIDS. One study, for example, revealed that highly educated 
black women still experienced poorer health than their equally educated white counterparts (Etherington 
2015), suggesting that intersecting identities may be an important part of health research and practice.  
However, the different ways in which intersectional identities play out in relation to health-risk 
behaviours and outcomes is not always clear. Intersectionality theory proposes that the effects of 
multiple minority or disadvantaged identities on health outcomes and behaviours are not merely 
additive in nature but complex and often counterintuitive (Bauer 2014). For example, contemporary 
literature on substance use and associated poor health identifies discrimination, oppression, as well as 
generally low wellbeing as factors affecting substance use behaviours (Priest et al. 2013; Frost and 




marginalised, and disadvantaged groups (Blosnich et al. 2011; Pollock et al. 2012). The literature also 
shows that people with intersecting identities, that is combinations or overlap of these group identities, 
are more likely to be marginalised and discriminated against and show lower levels of mental wellbeing 
(Carliner et al. 2016; Molina et al. 2016; Cook et al. 2016). Carliner et al. (2016) found that while racial 
discrimination against black Americans contributed to higher rates of illicit drug use, this relationship 
was even stronger amongst higher socioeconomic sections of this ethnic group. Further, Molina et al. 
(2016) found that while racial discrimination against Latinos generated higher risks of problematic 
alcohol use and smoking across men and women, men who identified strongly with their ethic/racial 
group were significantly more likely to be a current smoker than any other group. An interesting study 
by Cook et al. (2016) found that young men in the US aged 18 were more likely than the authors 
hypothesised to be forced into sex by woman (6% of men). Also, victims of assault by women were 
more likely to be engaging in substance use, specifically cannabis and crack cocaine. These kinds of 
findings highlight traditionally protective factors as ones that compound disadvantage in some 
circumstances. While the current body of literature provides some insight into the ways in which 
intersectionality affects health-risk behaviours in unexpected and complex ways (Walby et al 2012; 
Constance-Huggins 2018; Esposito and Edwards 2018), research on intersecting identities and 
substance use as well as intersectional health research beyond single-country samples is scarce. 
Furthermore, studies often concentrate on intersections with two identities, losing sight of highly 
complex and over-lapping social identities, and the ways in which these many lesser explored 
combinations impact differently on substance use behaviours. 
This paper presents the results of an intersectional analysis of a large international sample, 
addressing issues of substance use behaviour and risk among people with disadvantaged social 
identities, and the influence of potential interactions among those with multiple disadvantaged social 
identities. The aim of this paper is to identify protective and non-protective identity intersections and to 
determine the strength of relationships between social identities and intersections, and lifetime 





The Global Drug Survey (GDS) is the world’s largest annually conducted substance use survey. 
The GDS uses a non-probability sampling strategy with a self-administered anonymous online survey, 
available in ten different languages (Barratt et al. 2017). Social media platforms and media partners in 
19 countries were used to recruit participants for GDS2015. Questions are developed and reviewed by 
an expert advisory committee comprised of individuals with extensive expertise in the substance use 




Data from the 2015 wave of GDS (collected between November 11, 2014 and January 03, 2015) was 
used for this analysis. Ethical approval to conduct the survey was obtained from Joint South London 
and Maudsley National Health Service, the Institute of Psychiatry Joint Research Ethics Committee, 
and University of Queensland (Reference: 2017001452/11671/001). All participants provided informed 
consent before commencing the survey.  
 
Variables and measures 
Substances. This analysis includes binary variables on lifetime (yes/no) use of nine different 
substances: alcohol (also past year use), tobacco, cannabis, cocaine, amphetamine, MDMA (ecstasy), 
ketamine, methamphetamine, and GHB (gamma hydroxybutyrate). Commonly injected substances 
such as heroin were excluded from the analysis due to very low rates of lifetime use within the sample; 
however, all illicit substances in the data set were combined into one separate binary variable.  
Alcohol Use. The Alcohol Use Disorders Identification Test (AUDIT) was used to analyse 
drinking behaviour. AUDIT uses 10 standardised questions to calculate a score (range: 0 to 40), and 
has shown to be a valid and reliable measurement to identify patients with high risk/harmful levels of 
alcohol use at a cut-off of 15 points (Babor et al. 2001). Since alcohol is the most commonly used 
substance world-wide, lifetime use rates of alcohol are often not useful in largely adult samples as 
disparities will be at extremely low levels (Degenhardt et al. 2015; Daeppen et al. 2000).  
Demographic variables. Demographic indicators used for this analysis are age, educational 
level, country of residence, employment status, ethnicity, sexual identity, and gender.  
 
Analysis 
A total of 101,311 survey responses were submitted. After preparing the data, 3,456 records 
were excluded due to data capture glitches, duplicate entries, missing data on key variables (age, sex 
and drug screen items), and the reporting of using a fake drug. A further 6,914 participants were 
excluded from the analysis due to missing data on variables included in the analysis, with 4,200 
excluded for missing data on sexual orientation including 2,208 participants who preferred not to 
disclose their sexual orientation. Ethnicity and sexual orientation variables were recoded into 
dichotomous variables differentiating between majority/social advantaged social identity groups and 
minority identity status/disadvantaged social identities: Ethnicity (White/Caucasian as the socially 
advantaged identity and all other as the disadvantaged social identity), sexual orientation (heterosexuals 
as the social advantaged social identity and all other as the disadvantaged social identity). An 
international sample was used for this analysis including countries with various cultural backgrounds 
and traditions regarding the treatment of minorities. However, evidence suggests that all groups of 




disadvantaged across nations (Weiss and Bosia 2013; Chow et al. 2011) including nations in which, for 
example, non-White ethnicities are in the majority (Bhattacharyya et al. 2016).  
Descriptive analyses were conducted for sample characteristics (see Table 1). Multivariable 
logistic regressions were conducted to calculate adjusted odds ratios (AORs) of lifetime substance use 
(see Table 2) as well as harmful/high risk alcohol use (see Table 3). Disadvantaged social identity 
variables (ethnicity, sexual orientation, and gender), and demographic variables that have been found 
to influence substance use such as age, education, country of residence, and employment status (United 
Nations Office on Drugs and Crime 2015) were entered as independent variables using the 
majority/socially advantaged social identity as the reference category. Country of residence was entered 
as a fixed factor to account for potential differences between countries regarding legal systems and 
general substance use culture. Intersecting identities were entered as two-way and three-way 
interactions. Confidence intervals and probability values were calculated, but should be interpreted with 
caution due to the non-probabilistic nature of the sample. IBM SPSS Statistics Version 22 was used for 





The final sample used for analysis consisted of 90,941 participants with a mean age of 29.3 years (see 
Table 1). Most participants identified as male (62.1%, n=56,469), white/Caucasian (91.7%, n=83,390), 
and heterosexual (86.5%, n=78,631). Overall, participants possessed high levels of education with 
30.1% (n=27,231) and 14.2% (n=12,860) having undergraduate and postgraduate university degrees, 
respectively. One third (33%, n=29,969) of participants resided in Germany, and the 10 most common 
countries accounted for 84.2% of all participants. 
 
Substance use among individual minority groups 
Ethnicity. A total of 7,551 (8.3%) participants identified with a disadvantaged ethnic identity 
(see Table 1). Participants with a disadvantaged ethnic identity showed significantly higher AORs for 
lifetime substance (see Table 2 and 3) use for all substances included in this analysis except for tobacco 
and amphetamine, ranging from 1.24 (95-%-CI: 1.11-1.39, p<0.001) for ketamine to 2.45 (95-%-CI: 
2.00-3.01, p<0.001) for lifetime alcohol use. However, these participants showed a significantly lower 
AOR for past year alcohol use (AOR=0.76; 95-%-CI: 0.66-0.87, p<0.001); no differences in high 
risk/harmful alcohol use were detected.  
Sexual minority identities. A total of 12,310 (13.5%) participants identified with a sexual 




all illicit substances, amphetamine, cocaine, MDMA, ketamine, methamphetamine, and GHB, ranging 
from 1.20 (95-%-CI: 1.13-1.27, p<0.001) for amphetamine to 3.48 (95-%-CI: 3.17-3.83, p<0.001) for 
GHB. No differences in the use of tobacco, cannabis, and alcohol were found; however, sexual minority 
participants showed a significantly higher AOR for high risk/harmful alcohol use (AOR: 1.15, 95-%-
CI: 1.06-1.24, p<0.01). 
Female participants. Female comprised 37.9% (n=34,472) of the sample (see Table 1). Rates 
of substance use is generally lower among females compared to their male counterparts. AORs are 
significantly lower for all substances except lifetime alcohol use (AOR: 1.13, 95-%-CI: 1.00-1.26 
p<0.05), ranging from 0.48 (95-%-CI: 0.48-0.52, p<0.001) for all illicit substances and cannabis to 0.73 
(95-%-CI: 0.66-0.80, p<0.001) for GHB.  
 
Substance use and intersecting identities 
Intersection 1: ethnicity and sexual orientation. No significant differences could be detected for 
8 substances (amphetamine, tobacco, cocaine, MDMA, ketamine, methamphetamine, GHB, lifetime 
alcohol use, and past-year alcohol use) as well as for all illicit substances combined. Participants with 
an identity in this intersection have a significantly lower AORs for the use of all illicit substances (AOR: 
0.71, 95-%-CI: 0.55-0.93, p<0.05), cannabis (AOR: 0.72, 95-%-CI: 0.57-0.90, p<0.01), and high 
risk/harmful alcohol use (AOR: 0.70, 95-%-CI: 0.53-0.94, p<0.05). 
Intersection 2: ethnicity and gender. AORs were significantly lower for six substances: all illicit 
substances (AOR: 0.59, 95-%-CI: 0.51-0.68,p<0.001), tobacco (AOR: 0.80, 95-%-CI: 0.70-
0.91,p<0.01), cannabis (AOR: 0.61, 95-%-CI: 0.53-0.70, p<0.001), cocaine (AOR: 0.78, 95-%-CI: 
0.69-0.87, p<0.001), MDMA (AOR: 0.81, 95-%-CI: 0.72-0.91, p<0.001), and methamphetamine 
(AOR: 0.61, 95-%-CI: 0.45-0.84, p<0.01); no significant differences were detected for amphetamine, 
ketamine, and GHB as well as lifetime/past year and high risk/harmful alcohol use. Participants with 
this intersecting identity had higher AORs for all substances except methamphetamine and past year 
alcohol consumption than females alone and lower AORs for all substances than ethnic minority 
participants except past year alcohol consumption. However, participants with this intersecting identity 
showed lower AORs for high risk/harmful alcohol consumption (AOR: 0.70, 95-%-CI: 0.53-0.94, 
p<0.05) than both female and ethnic minority participants alone.  
Intersection 3: gender and sexual orientation. AORs for substance use were significantly higher 
for six substances: all illicit substances combined (AOR: 1.47, 95-%-CI: 1.30-1.66, p<0.001), 
amphetamine (AOR: 1.62, 95-%-CI: 1.47-1.78, p<0.001), tobacco (AOR: 1.76, 95-%-CI: 1.56-1.98, 
p<0.001), cannabis (AOR: 2.02, 95-%-CI: 1.81-2.25, p<0.001), cocaine (AOR: 1.23, 95-%-CI: 1.13-
1.35, p<0.001), and MDMA (AOR: 1.26, 95-%-CI: 1.15-1.37, p<0.001). AORs for GHB use were 
significantly lower (AOR: 0.58, 95-%-CI: 0.49-0.69, p<0.001) and no significant differences could be 




participants with this intersecting identity had a higher AOR of high risk/harmful alcohol use (AOR: 
1.37, 95-%-CI: 1.21-1.55, p<0.001). Participants with this intersection had higher AORs for all 
substances compared to females alone with the exception of lifetime and past year alcohol use. They 
also showed higher AORs than those with a sexual minority identity alone for all illicit substances, 
amphetamine, tobacco, cannabis, cocaine, MDMA, and lower AORs for ketamine, methamphetamine, 
GHB as well as lifetime, past year and high risk/harmful alcohol consumption. 
Intersection 4: Ethnic minority, sexual minority, and female. Participants with this intersecting 
identity have significantly higher AORs of substance use for four substances: all illicit substances 
(AOR: 2.08, 95-%-CI: 1.44-3.02, p<0.001), cannabis (AOR: 2.1, 95-%-CI: 1.49-2.94, p<0.001), 
cocaine (AOR: 1.36, 95-%-CI: 1.05-1.77, p<0.05), and MDMA (AOR: 1.41, 95-%-CI: 1.09-1.83, 
p<0.05). No significant differences could be detected for other substances or high risk/harmful alcohol 
use. Compared with participants in intersection 1 (ethnicity and sexual orientation), participants in this 
intersection showed higher AORs for all substances except ketamine, GHB, and past year alcohol use. 
Similarly they also showed higher AORs for all substances except tobacco, ketamine and high 
risk/harmful alcohol consumption compared to those in intersection 3 (sex and sexual orientation) as 
well as higher AORs than those in intersection 2 (ethnicity and sex) for all substances except past year 




This paper addresses issues of substance use among people with disadvantaged social identities 
and the potential influence of interactions between these identities on substance use disparities. The 
current body of literature on substance use identifies discrimination, oppression, and marginalisation 
(Gibbons et al. 2012; Meyer 2003) as well as generally low wellbeing (Degenhardt et al. 2001; Merline 
et al. 2004) as factors increasing substance use behaviours. Literature also shows that people with 
intersecting identities are more likely to be marginalised and discriminated against and have lower 
levels of wellbeing (Frost and Meyer 2009; Meyer 2003; Priest et al. 2013; Stuber et al. 2008). 
The analysis of this study suggests that participants with disadvantaged ethnic identities or a 
sexual minority identity are meaningfully more likely to be involved in substance use in their lifetime. 
The third group of participants with a disadvantaged social identity in this analysis, females, are 
generally less likely to experience substance use and high risk/harmful alcohol use than their male 
counterparts. This analysis also shows that participants with multiple intersecting identities are not 
necessarily more likely to experience substance use than those without or only one minority or 
oppressed identity. Results suggest that participants with an intersecting identity comprised of a 
disadvantaged ethnic identity and a sexual minority identity are considerably less likely to use 




identity. Participants with this intersection identity also showed generally lower AORs than those 
participants with just one of these minority identities. This intersection might be a protective factor in 
the context of substance use. This effect could not be observed for the intersection of ethnic minorities 
and female identities, showing that ethnic minority females are less likely to use substances than ethnic 
minority participants in general but more than females in general.  
Similarly, the analysis of the intersecting identity of females and sexual minority shows an 
increase in lifetime substance use behaviour as well riskier alcohol use. Finally, this analysis showed 
that a more complex intersecting identity between ethnic and sexual minority and females may not be 
protective for all groups. Participants with these intersecting identities are generally more likely to 
experience substance than all other intersecting identities in this analysis.  
Previous studies showed lower levels of substance use for females and heterosexuals compared 
to males and sexual minority participants, respectively, consistent with the results of this analysis 
(Agaku et al. 2014; Hatzenbuehler et al. 2014). Current literature also supports the conclusion that 
females with intersecting identities may be at higher risk of substance use (Marshal et al. 2008; Mereish 
and Bradford 2014) whilst sexual and ethnic minority are at a lower risk of substance use than their 
respective white counterparts (Blosnich et al. 2011; Mereish and Bradford 2014; Pollock et al. 2012). 
This analysis showed that these trends are consistent using a variety of substances in an international 
sample beyond English-speaking countries.  
 
Strengths and limitations 
The study has some limitations. Participants responding to the Global Drug Survey were more 
likely to be younger, higher educated, and sexually diverse than the general population, while women 
and ethnic minorities were underrepresented. There are multiple potential reasons for these differences 
including the recruitment through media partners often described as politically liberal as well as the 
name of the study potentially attracting populations known for higher rates of substance use such as 
men (compared to women). This may inflate rates of substance use observed in this study. Similarly, 
participants are self-enrolled, further restricting the generalisability of results. However, the design of 
this survey might be better than population surveys at recruiting participants from hard-to-reach 
populations such as people with an intersecting identity (Barratt et al. 2017). A small number of 
participants with complex intersecting identities may not be included in the analysis due to missing data 
on sexual orientation. It is not clear why a considerable number of participants prefers not to disclose 
their sexual orientation. Participants may be uncertain about their own sexual orientation or feel 
uncomfortable to disclose their sexual orientation due to various reasons such as living in an 
environment perceived to be hostile towards sexual minority identities. Furthermore, it is unknown how 
many participants used a substance only once; lifetime substance use might therefore not be the most 




Previous research has also identified marital status as a protective factor against substance use (Merline 




Overall, among people responding to a web survey on substance use, people who belong to an 
ethnic and/or sexual minority were more likely to report the use of various substances across their 
lifetime. The findings support the need of more research into the health of people with intersecting 
identities as a public health priority, particular in regards to disparities in substance use outcomes in 
sexual minority women from an ethnic minority. Similarly, qualitative studies are needed to identify 
potential coping strategies used by sexual minority men from an ethnic minority, why these are not 
employed by or do not work for sexual minority women. Furthermore, research into the effects and 
potential role of minority communities on substance use are needed, especially on how positive 
mechanisms in these communities can be used in designing public health interventions. Future study 
designs should ensure that people with a minority identity are sufficiently reached, for example by 
partnering with community media and within social media networks.  
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Table 1: Global Drug Survey (2015) sample characteristics (n=90,941) 
 % of 
total 
Gender Male  62.1 
Female 37.9 











No formal schooling 0.2 
Primary school 1.2 
Secondary school 20.9 
Technical education 6.9 
College certificate 26.6 
Undergraduate degree 30.1 
Postgraduate degree 14.2 
Country of residence Germany 33.0 
France 8.9 
United Kingdom 6.4 






New Zealand 3.4 
Other 15.8 
 Mean 
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Table 3: Lifetime, Recent, and High Risk/Harmful Alcohol Cnsumption by Identity, Global Drug Survey (2015) 
Variables 
Alcohol (Lifetime) Alcohol (Last year) 
High Risk/Harmful 
Alcohol Consumption# 
AOR^ 95%CI AOR^ 95%CI AOR^ 95%CI 
Ethnicity       
White/Caucasian 1†  1†  1†  









Heterosexual 1†  1†  1†  
Sexual Minority 1.08 0.85-1.36 1 0.89-1.12 1.15** 1.06-1.24 
Sex       
Male 1†  1†  1†  
Female 1.20** 1.05-1.38 0.92* 0.86-0.99 0.63*** 0.59-0.66 










Ethnicity × Sex 0.78 0.58-1.07 0.96 0.78-1.19 1.09 0.91-1.3 


















Legend: † Reference, * p< 0.05, ** p< 0.01, *** p< 0.001, ^ Adjusted Odds Ratio, adjusted for age, educational status, country of 
residence, employment status, # Alcohol Use Disorders Identification Test (AUDIT) score above 15 
 
 
 
